STAT+: Astellas treatment offers new hope to a devastated rare disease community

Astellas has a new treatment that offers hope to a rare disease community, amidst turmoil at the FDA and updates on gene therapy and Alzheimer's drug adoption. The FDA is facing questions over Commissioner Marty Makary's position. Astellas' treatment brings new possibilities for a once-devastated rare disease program.